GovChime
Notice ID: 521d19fffdbe44cebd43489c5e8c172fCombined Synopsis/Solicitation

High-throughput SARS-CoV-2 AlphaLISA screening for COVID-19 drug discovery

Archived on September 21, 2021. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−04:00
Posted
August 26, 2021
Notice type
Combined Synopsis/Solicitation
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75N95021Q00394
Notice ID
521d19fffdbe44cebd43489c5e8c172f

Description

**Please see attached non-competitive combined synopsis solicitation**

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95021Q00394
  1. Combined Synopsis
  1. Combined SynopsisCurrentAug 26, 2021

    High-throughput SARS-CoV-2 AlphaLISA screening for COVID-19 drug discovery

    Notice 521d19fffdbe44cebd43489c5e8c172f on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.
63%
Market Research12/04/2026
59%
Market Research11/09/2026
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST.
59%
Solicitation11/04/2026
The South Texas Veterans Health Care System requires contractor services to perform testing and certification of sterile compounding facilities, including primary and secondary engineering controls as described in the attached Performance Work Statement (PWS), at the Audie L. Murphy Memorial VA Hospital Pharmacy Service. All work shall be performed in accordance with applicable standards and the related testing described in the attached PWS. The contractor shall provide all labor, equipment, and documentation needed to fulfill the requirements outlined in the PWS.
59%
Combined Synopsis11/17/2026
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces.
59%
Pre-Solicitation11/02/2026

Additional Details

Solicitation Number

75N95021Q00394

Archive Date

Sep 21, 2021

Office Address

Bethesda, MD, 20892